Intravenous iron
Intravenous iron is a pharmaceutical drug with 7 clinical trials. Currently 1 active trials ongoing. Historical success rate of 100.0%.
Success Metrics
Based on 2 completed trials
Phase Distribution
Phase Distribution
1
Early Stage
1
Mid Stage
3
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
100.0%
2 of 2 finished
0.0%
0 ended early
1
trials recruiting
7
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Restoring Iron Deficiency in POTS
Efficacy of Treatment of Postpartum Anaemia With Intravenous Iron Versus Oral Iron in a Tertiary Hospital in South East, Nigeria.
Management of Anemia in Patients with EndocaRditis Infectious Candidates for Cardiac Surgery: the AMERICA Study
Predicting Response to Iron Supplementation in Patients With Active Inflammatory Bowel Disease
.Patient Blood Management Program in Liver Transplantation
Clinical Trials (7)
Restoring Iron Deficiency in POTS
Efficacy of Treatment of Postpartum Anaemia With Intravenous Iron Versus Oral Iron in a Tertiary Hospital in South East, Nigeria.
Management of Anemia in Patients with EndocaRditis Infectious Candidates for Cardiac Surgery: the AMERICA Study
Predicting Response to Iron Supplementation in Patients With Active Inflammatory Bowel Disease
.Patient Blood Management Program in Liver Transplantation
Intravenous Versus Oral Iron Therapy in Hemodialysis Patients
Intravenous Iron in Gynecologic Cancer Patients Receiving Chemotherapy
All 7 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 7